June 1, 2017 at 11 am PT/2 pm ET
Webinar: Understanding Alpha-1 Antitrypsin Deficiency
Join us and James K. Stoller, MD, MS, of the Cleveland Clinic as he discusses alpha-1 antitrypsin deficiency (AATD), a relatively common genetic condition that is frequently under-recognized and diagnosed late.1 Given that an estimated 1–3% of patients with COPD have AATD2, many primary care providers are likely already caring for undiagnosed AATD patients.
In this webinar, Dr. Stoller will discuss AATD epidemiology, diagnostic testing, current therapeutic options and implications for patients’ families. Dr. Stoller has published extensively on COPD, especially AATD, and on strategies for delivering care.
This webinar is designed for primary care practitioners and all allied health professionals interested in improving recognition and diagnosis of AATD in their practice.
1. Stoller, James K. et al. “Delay In Diagnosis Of Α1-Antitrypsin Deficiency”. Chest 128.4 (2005): 1989-1994.
2. Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 1986; 89:370.